Uploaded October 2022 | Updated September 2026, 2 weeks ago
This video features an interview with 2022–2023 Positive Droplet Award recipient, Dr. Remco de Kock. Dr. de Kock was recognized as a Digital PCR recipient for his positive contributions in the field of oncology, lung cancer. Dr. de Kock worked on the development and implementation of multiplex Droplet Digital™ PCR (ddPCR™) assays for the detection of the most relevant driver and therapy resistance mutations in circulating tumor DNA (ctDNA) to support the diagnosis and therapy response monitoring of lung cancer in routine clinical practice.
Learn more about Dr. Remco de Kock and his achievements with ddPCR technology that made him stand out amongst his peers, and discover how you can nominate or become a Positive Droplet Award recipient at bio-rad.com/positive-droplet-awards.
Be sure to like this video and subscribe to the channel.
We Are Bio-Rad.
Our mission: To provide useful, high-quality products and services that advance scientific discovery and improve healthcare. At Bio-Rad, we are united behind this effort. These two objectives are the driving force behind every decision we make, from developing innovative ideas to building global solutions that help solve our customers' greatest challenges.
Connect with Bio-Rad Online:
Website: bio-rad.com/digital-pcr
LinkedIn: linkedin.com/company/bio-rad
Facebook: facebook.com/BioRadGenomics
Twitter: twitter.com/BioRadGenomics
Instagram: instagram.com/bioradlabs/?hl=en
©2022 Bio-Rad is a trademark of Bio-Rad Laboratories, Inc. in certain jurisdictions. All trademarks used herein are the property of their respective owner.
#ddpcr #positivedropletawards #oncology
Music used by permission granted by royalty-free license from Pond5.com
This video features an interview with 2022–2023 Positive Droplet Award recipient, Dr. Remco de Kock. Dr. de Kock was recognized as a Digital PCR recipient for his positive contributions in the field of oncology, lung cancer. Dr. de Kock worked on the development and implementation of multiplex Droplet Digital™ PCR (ddPCR™) assays for the detection of the most relevant driver and therapy resistance mutations in circulating tumor DNA (ctDNA) to support the diagnosis and therapy response monitoring of lung cancer in routine clinical practice.
Learn more about Dr. Remco de Kock and his achievements with ddPCR technology that made him stand out amongst his peers, and discover how you can nominate or become a Positive Droplet Award recipient at bio-rad.com/positive-droplet-awards.
Be sure to like this video and subscribe to the channel.
We Are Bio-Rad.
Our mission: To provide useful, high-quality products and services that advance scientific discovery and improve healthcare. At Bio-Rad, we are united behind this effort. These two objectives are the driving force behind every decision we make, from developing innovative ideas to building global solutions that help solve our customers' greatest challenges.
Connect with Bio-Rad Online:
Website: bio-rad.com/digital-pcr
LinkedIn: linkedin.com/company/bio-rad
Facebook: facebook.com/BioRadGenomics
Twitter: twitter.com/BioRadGenomics
Instagram: instagram.com/bioradlabs/?hl=en
©2022 Bio-Rad is a trademark of Bio-Rad Laboratories, Inc. in certain jurisdictions. All trademarks used herein are the property of their respective owner.
#ddpcr #positivedropletawards #oncology
Music used by permission granted by royalty-free license from Pond5.com
